trial · primary record
BCMA CAR-T
Multiple Myeloma, Newly Diagnosed
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2029-08-01 |
| Primary endpoint | Sustained MRD-negative rate |
| Registry ID | NCT07106736 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:42.700Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07106736
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.